NASDAQ : VOGX

Vogenx, Inc. — Key statistics

Healthcare · Biotechnology · United States

Last price 20.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 300.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap300.82M
Enterprise Value301.49M

Dates

MeasureValue
Earnings DateNov 19, 2026
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class14.86M
Shares Outstanding14.86M
Shares Change (YoY)n/a
Shares Change (QoQ)+0.00%
Owned by Insiders (%)33.97%
Owned by Institutions (%)15.47%
Float9.81M

Ratios

MeasureValue
PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Evratios

MeasureValue
EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financialposition

MeasureValue
Current Ratio0.44
Quick Ratio0.06
Debt / Equityn/a
Debt / EBITDAn/a
Debt / FCFn/a
Interest Coveragen/a

Financialefficiency

MeasureValue
Return on Equity (ROE)n/a
Return on Assets (ROA)n/a
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)88.51%
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee-$330,814
Employee Count5
Asset Turnovern/a
Inventory Turnovern/a

Taxes

MeasureValue
Income Taxn/a
Effective Tax Raten/a

Stockprice

MeasureValue
Beta (5Y)n/a
52-Week Price Changen/a
50-Day Moving Average24.68
200-Day Moving Averagen/a
Relative Strength Index (RSI)52.57
Average Volume (20 Days)95,721

Shortselling

MeasureValue
Short Interest38,289
Short Previous Month26,831
Short % of Shares Out0.26%
Short % of Float0.39%
Short Ratio (days to cover)0.29

Incomestatement

MeasureValue
Revenuen/a
Gross Profitn/a
Operating Income-1.57M
Pretax Income-1.65M
Net Income-1.65M
EBITDAn/a
EBIT-1.57M
Earnings Per Share (EPS)-$0.30

Balancesheet

MeasureValue
Cash & Cash Equivalents193,017
Total Debt867,700
Net Cash-674,683
Net Cash Per Share-$0.05
Equity (Book Value)-1.78M
Book Value Per Share-0.34
Working Capital-1.78M

Cashflow

MeasureValue
Operating Cash Flow-862,385
Capital Expendituresn/a
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flown/a
FCF Per Sharen/a

Margins

MeasureValue
Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield-1.50%
FCF Yieldn/a

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Scoren/a
Piotroski F-Score1

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a